MSACL 2016 US Abstract

Quantitation of 22 Long Chain Fatty Acids by GC-NCI-MS in Serum and Plasma

Erik Kish-Trier (Presenter)
ARUP Laboratories

Authorship: Erik Kish-Trier, Aiping Liu, Maria Erali, Tatiana Yuzyuk
ARUP Institute for Clinical and Experimental Pathology,

Short Abstract

Long chain fatty acids (LCFAs) play diverse and critical biological roles. Here we present a GC-NCI-MS method for quantitation of 22 LCFAs (C12-C22) in serum/plasma, including the essential and conditionally essential polyunsaturated LCFAs. Hydrolysis was used to release bound LCFAs, which were extracted in hexane and derivatized to form pentafluorobenzyl esters. Our GC strategy gave baseline separation for most analytes, prior to being ionized by NCI and detected in SIM mode. This method offers several advantages upon published studies by using a single injection, additional internal standards, and backflush technology. Validation data and updated reference ranges are presented.

Long Abstract

Long chain fatty acids (LCFAs) play diverse and critical biological roles. Here we present a GC-NCI-MS method for quantitation of 22 LCFAs (C12-C22) in serum/plasma, including the essential and conditionally essential polyunsaturated LCFAs. Hydrolysis was used to release bound LCFAs, which were extracted in hexane and derivatized to form pentafluorobenzyl esters. Our GC strategy gave baseline separation for most analytes, prior to being ionized by NCI and detected in SIM mode. This method offers several advantages upon published studies by using a single injection, additional internal standards, and backflush technology. Validation data and updated reference ranges are presented.


References & Acknowledgements:


Financial Disclosure

DescriptionY/NSource
Grantsno
SalaryyesARUP Laboratories
Board Memberno
Stockno
ExpensesyesARUP Laboratories

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no